Evolent Health (EVH) Acquisitions (2015 - 2025)

Evolent Health has reported Acquisitions for 11 years, with the latest figure at $1.4 million in Q4 2025.

• On a quarterly basis, Acquisitions fell 89.85% year-over-year to $1.4 million in Q4 2025; TTM through Jun 2026 was $1.4 million, a 98.27% decrease from a year earlier, with the FY2025 full-year figure at $57.4 million, up 86.96% from the prior year.
• Acquisitions was $1.4 million for Q4 2025 at Evolent Health, up from -$2000.0 in the prior quarter.
• The five-year high for Acquisitions was $386.7 million in Q1 2023, with the low at -$2000.0 in Q3 2025.
• Average Acquisitions over 5 years is $45.5 million, with a median of $4.5 million recorded in 2025.
• The sharpest annual moves came in 2023 and 2025: Acquisitions surged 552362.86% in 2023, then slumped 100.02% in 2025.
• Over 5 years, Acquisitions stood at $47.1 million in 2021, then tumbled by 93.44% to $3.1 million in 2022, then plunged by 50.74% to $1.5 million in 2023, then surged by 805.26% to $13.8 million in 2024, then sank by 89.85% to $1.4 million in 2025.
• The last three Acquisitions figures came in at $1.4 million (Q4 2025), -$2000.0 (Q3 2025), and $51.5 million (Q2 2025), per Business Quant data.